Prisma Health Richland Hospital is a hospital in Columbia, South Carolina that is part of Prisma Health. Prisma Health Richland hospital was originally established in 1892 as Columbia Hospital and was one of the first hospitals in the city.

During the past decade, Prisma Health Richland Hospital conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 77 clinical trials were completed, i.e. on average, 97.5% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 24 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Richland Hospital" #1 sponsor was "Children's Oncology Group" with 74 trials, followed by "National Cancer Institute (NCI)" with 50 trials sponsored, "Prisma Health-Midlands" with 6 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Abbott Medical Devices" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Richland Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 78 trials as a collaborator, "Medical University of South Carolina" with 6 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "Children's Oncology Group" with 4 trials as a collaborator and "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Richland Hospital" are "Recurrent Neuroblastoma" (18 trials), "Recurrent Osteosarcoma" (14 trials), "Refractory Neuroblastoma" (12 trials), "Refractory Non-Hodgkin Lymphoma" (11 trials) and "Recurrent Hepatoblastoma" (10 trials). Many other conditions were trialed in "Prisma Health Richland Hospital" in a lesser frequency.

Most popular intervention types in "Prisma Health Richland Hospital" are "Drug" (135 trials), "Other" (95 trials), "Procedure" (60 trials), "Biological" (55 trials) and "Radiation" (39 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Cyclophosphamide" (40 trials), "Vincristine Sulfate" (35 trials), "Doxorubicin Hydrochloride" (29 trials) and "Etoposide" (26 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Richland Hospital" are 176 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 99 active trials in "Prisma Health Richland Hospital". 1 are not yet recruiting, 49 are recruiting, 47 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 69 completed trials in Prisma Health Richland Hospital, 4 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Richland Hospital, 6 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 85 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".